Pharmacokinetics of imipenem/cilastatin sodium in children with peritonitis.
Fifteen children (3-12 years) with peritonitis were given imipenem/cilastatin intravenously (15 or 25 mg/kg) every six hours for 3-14 days. One day during treatment days 2-8, multiple blood and urine samples were collected from each individual over a six hour dosing interval. Twelve children completed the study. The urinary recovery of imipenem and cilastatin averaged 50-70% of the administered dose. The plasma t1/2 for imipenem averaged 55 min. while that for cilastatin was even more rapid (approximately 38 min.). Little or no accumulation of either imipenem or cilastatin was observed for this regimen in this age group of paediatric patients. Steady state conditions prevailed within 2 days of initiation of therapy. The pharmacokinetics of imipenem and cilastatin in paediatric patients 3-12 years of age appear similar to those observed for adults.
Claesson
G
G
Department of Paediatric Surgery, Karolinska Institute, St. Görans Hospital, Stockholm, Sweden.
Eriksson
M
M
Rogers
J D
JD
D002648:Child; D002675:Child, Preschool; D015377:Cilastatin / Q000493:pharmacokinetics*; D004359:Drug Therapy, Combination; D006801:Humans; D015378:Imipenem / Q000493:pharmacokinetics*; D007262:Infusions, Intravenous; D010538:Peritonitis / Q000378:metabolism*
D015377:Cilastatin; D015378:Imipenem